Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression...

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Mechanisms of follicular thyroid cancer (FTC) invasiveness remain unclear.
• Follicular thyroid tumors encompass both adenomas (FTA) and carcinomas (FTC).
• Understanding transcriptional differences is crucial for diagnosing and treating thyroid neoplasms.

Purpose of the Study:

• To investigate if malignant phenotype influences major sources of variability in follicular thyroid tumors.
• To identify gene expression patterns differentiating follicular thyroid adenomas (FTA) from follicular thyroid carcinomas (FTC).
• To explore the role of immune response genes in follicular thyroid tumor invasiveness.

Main Methods:

• Unsupervised analysis of 52 follicular thyroid tumors (27 FTC, 25 FTA) using oligonucleotide microarrays.
• Principal Component Analysis (PCA) applied to identify major sources of gene expression variability.
• Clustering analysis based on gene expression patterns correlated with principal components.

Main Results:

• Follicular thyroid carcinomas (FTC) and adenomas (FTA) showed distinct transcriptional profiles.
• Genes upregulated in adenomas included thyroid-specific transcripts, while carcinomas showed upregulation of immunity-related transcripts.
• Immune response genes were identified across multiple principal components, aiding discrimination between FTC and FTA.

Conclusions:

• Tumor invasiveness appears to be a major source of transcriptome variability in follicular thyroid tumors.
• While distinct patterns exist, unsupervised analysis alone is insufficient for definitive classification due to overlapping clusters.
• Further research is needed to refine classification and understand the role of immune responses in FTC progression.